Paco_the_Dirty_Gringo Posted - 1 day ago

$PTIX $NRIX is advancing with novel immunotherapies, and $PTIX is pushing forward with groundbreaking CNS therapies. Both companies are on a trajectory toward major growth in the biotech space.

briefingcom Posted - 3 days ago

$NRIX: Nurix Therapeutics receives U.S. FDA fast track designation for NX-5948 for the treatment of relapsed or refractory waldenstrom’s macroglobulinemia https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241219070833NRIX&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

OpenOutcrier Posted - 3 days ago

$NRIX (-5.1% pre) Nurix Therapeutics (NRIX) Receives FDA Fast Track Designation for NX-5948 - SI https://ooc.bz/l/51290

Avocado_smash Posted - 5 days ago

$NRIX Signal turn bullish, PT 22.95/23.70

justiceforb_85 Posted - 1 week ago

$NRIX wondering what the bear thesis is here? NX-5948 has strong data.

SamiraSexton Posted - 1 week ago

🔥 Bolt Metals (CSE: BOLT) (PCRCF.US) 🚨 1M volume in 1h of market opens, this is 6x avg. ALL IS BUYING !!! Bolt could be next in line for a major partnership or JV! 💥 With their Northwind property just 15 km from Osisko's Windfall gold deposit, and Gold Fields dropping C$2.16B to acquire Osisko, the Urban-Barry camp is on 🔥. Drill-ready targets + prime location = serious upside potential for this junior miner. Could BOLT be the next big gold play? 🚀 $HRMY $NMRA $NRIX

NVDAMillionaire Posted - 1 week ago

$NRIX Nurix Therapeutics (NRIX): Pioneering the Field of Targeted Protein Modulation https://beyondspx.com/article/nurix-therapeutics-nrix-pioneering-the-field-of-targeted-protein-modulation

Quantumup Posted - 1 week ago

H.C. Wainwright⬆️the PT on $NRIX to $35 was $30/Buy +⬆️NX-5948s probability of approval to 60% was 50%, after Nurix presented updated '5948🔬at #ASH24. HCW views NX-5948s ORR as highly favorable and relatively in-line with that seen for the $BGNE BTK degrader: $kymr $arvn

OptionRunners Posted - 1 week ago

$NRIX Buyer of the January 17th 2025 $20 calls (ITM) 1,600 times for $3.50 - $4.00

OpenOutcrier Posted - 1 week ago

$NRIX (+3.1% pre) Nurix Therapeutics's SWOT analysis: btk degrader stock shows promise amid challenges - inv https://ooc.bz/l/50269

hitmongreen Posted - 1 week ago

$NRIX 🧐

justiceforb_85 Posted - 2 weeks ago

$NRIX hoping for positive data from ASH.

Quantumup Posted - 2 weeks ago

BMO Capital🏁 $NRIX Outperform/$35. $kymr $arvn BMO Capital said in its research report: "'Nurix Therapeutics, Inc.: Initiate at OP: DeGrader BTK Approach a Driver of Upside' We initiate coverage of $NRIX at Outperform with a $35 target price, as we believe the company is poised to deliver significant growth with its protein degradation platform. NRIX's BTK degrader, NX-5948, is demonstrating that degradation of the BTK protein can lead to clinical responses in patients that have progressed on prior lines of targeted therapies. Given the size of the current BTK market and the opportunity to expand into new indications, we believe $NRIX is well-positioned for long-term growth with additional optionality in the rest of its pipeline.

OpenOutcrier Posted - 2 weeks ago

$NRIX (+8.5% pre) Nurix Therapeutics Announces Webcast To Review New Data from Its Phase 1 Clinical Trial of BTK Degrader NX-5948 Presented at the 66th American Society of Hematology (ASH) Annual Meeting - SI https://ooc.bz/l/49315

MaxDanger Posted - 11/25/24

$NRIX ASH in a couple weeks will be very interesting for this stock. There will likely be a lot of talk about this degrader and $BGNE degrader that are both going to come out around the same time. The data is spectacular on both so far. This will likely be scooped up by an AZ or something.

OpenOutcrier Posted - 1 month ago

$NRIX (+4.9% pre) Nurix Therapeutics (NRIX) Receives PRIME Designation from the European Medicines Agency for NX-5948 - SI https://ooc.bz/l/48931

DonCorleone77 Posted - 1 month ago

$NRIX Nurix Therapeutics announces PRIME designation for NX-5948 from EMA Nurix Therapeutics announced that the European Medicines Agency, or EMA, has granted PRIME designation for NX-5948, a highly selective degrader of Bruton's tyrosine kinase, for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma after at least a BTK inhibitor and a BCL-2 inhibitor. To be eligible for PRIME, medicines must target an unmet medical need and show potential benefit for patients based on early clinical data.

LewisDaKat Posted - 1 month ago

$NRIX News out Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024 https://marketwirenews.com/news-releases/nurix-therapeutics-presents-preclinical-data-from-tw-5258283445262982.html $NRIX

oaksapollo Posted - 1 month ago

$NRIX looks like Cathie sold https://cathiesark.com/arkg-holdings-of-nrix

insiderbuyingselling Posted - 1 month ago

$NRIX new insider selling: 3290 shares. http://insiderbuyingselling.com/?t=NRIX

insiderbuyingselling Posted - 1 month ago

$NRIX new insider selling: 5760 shares. http://insiderbuyingselling.com/?t=NRIX

insiderbuyingselling Posted - 10/31/24

$NRIX new insider selling: 3437 shares. http://insiderbuyingselling.com/?t=NRIX

themacromindset Posted - 2 months ago

$NRIX Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia

themacromindset Posted - 2 months ago

$NRIX Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur

insiderbuyingselling Posted - 2 months ago

$NRIX new insider selling: 3290 shares. http://insiderbuyingselling.com/?t=NRIX

Thestocktraderhubzee Posted - 2 months ago

$NRIX RBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $26

FlynancialAnalyst Posted - 2 months ago

$NRIX $1.41B mc $XBI name with a hammer close & remount of 10 wk SMA on volume as price continues to defend key $20 level Short squeeze under way as short float % continues to decline from 23.56% to now 17.78% YTD Pct of all funds long shares at record highs & rising quickly TrendEdge.app/asset/NRIX

LewisDaKat Posted - 2 months ago

News Article $NRIX Nurix Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Provides a Corporate Update https://marketwirenews.com/news-releases/nurix-therapeutics-reports-third-quarter-fiscal-2024-7020814358952240.html $NRIX

DonCorleone77 Posted - 2 months ago

$NRIX Nurix Therapeutics reports Q3 EPS (67c), consensus (69c) Reports Q3 revenue $12.59M, consensus $13.25M. "We continue to make great progress and remain focused on execution as we advance our pipeline of wholly owned and partnered programs in oncology, inflammation and immunology," said Arthur Sands, president and chief executive officer of Nurix. "As we approach the end of the year, we are well capitalized and look forward to building further momentum as we head into clinical data readouts in the fourth quarter of 2024 and the initiation of pivotal studies of NX-5948 in 2025."

insiderbuyingselling Posted - 2 months ago

$NRIX new insider selling: 5760 shares. http://insiderbuyingselling.com/?t=NRIX